Trial Summary
What is the purpose of this trial?
This trial tests a small tube called the GORE® VIAFORT Vascular Stent to help adults with blocked veins. The stent keeps the veins open so blood can flow properly.
Research Team
Kush Desai, MD
Principal Investigator
Northwestern University
SB
Stephen Black, MD, FRCS (Ed), FEBVS
Principal Investigator
Guy's and St Thomas' NHS Foundation Trust
Eligibility Criteria
Adults over 18 with symptomatic vein blockages in the legs, able to follow treatment and check-up plans, not pregnant or planning pregnancy within a year. Excludes those with severe kidney issues, recent surgeries, significant blood clots in lungs, low hemoglobin levels, bleeding disorders, current participation in conflicting studies, major leg amputations, certain genetic conditions or drug sensitivities.Inclusion Criteria
Patient is able to provide informed consent.
My vein condition is severe or causes me significant pain.
I am 18 years old or older.
See 5 more
Exclusion Criteria
I currently have or might have an infection.
You have used illegal drugs through a needle in the past year.
My BMI is over 40.
See 14 more
Treatment Details
Interventions
- GORE® VIAFORT Vascular Stent (Vascular Stent)
Trial OverviewThe trial is testing the GORE® VIAFORT Vascular Stent's performance and safety for treating adults with blocked veins in their lower body. It's a forward-looking study across multiple centers where all participants receive the stent without being compared to another group.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: GORE® VIAFORT Vascular StentExperimental Treatment1 Intervention
GORE® VIAFORT Vascular Stent
Find a Clinic Near You
Who Is Running the Clinical Trial?
W.L.Gore & Associates
Lead Sponsor
Trials
103
Recruited
32,900+
Bret Snyder
W.L.Gore & Associates
Chief Executive Officer since 2020
MBA from Stanford University
Dr. John Doe
W.L.Gore & Associates
Chief Medical Officer since 2023
MD from Harvard Medical School